Genetic Signatures Ltd Cash Flow Quality Index

Latest as of December 2021: 1.68x

Genetic Signatures Ltd cash flow quality index. Genetic Signatures Ltd (GSS) has a Cash Flow Quality Index of 1.68x as of December 2021. Operating cash flow of AU$7.88 Million exceeds net income of AU$4.70 Million, indicating high earnings quality where cash backs reported profits. Explore Genetic Signatures Ltd (GSS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.68x
Operating CF / Net Income

Operating Cash Flow

AU$7.88 Million
AUD

Net Income

AU$4.70 Million
AUD

Data as of

Dec 2021
Most recent filing

Cash Flow Quality Index of Genetic Signatures Ltd (2021–2022)

Cash flow quality index of Genetic Signatures Ltd from 2021 to 2022. Historical Cash Flow Quality Index for Genetic Signatures Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Genetic Signatures Ltd (GSS) net asset quality to measure how much of total assets are equity-financed.

Genetic Signatures Ltd Cash Flow Quality Index by Year (2021–2022)

Genetic Signatures Ltd cash flow quality index by year from 2021 to 2022. Year-by-year earnings quality comparison for Genetic Signatures Ltd. For the full cash flow conversion analysis, see Genetic Signatures Ltd operating cash flow efficiency.

Year Quality Index Operating CF (AUD) Net Income YoY Change
2022 3.20x AU$9.81 Million AU$3.06 Million ▲ +34.0%
2021 2.39x AU$4.20 Million AU$1.76 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.